A first: All respond to gene therapy in a blood cancer study – Northwest Herald
|
A first: All respond to gene therapy in a blood cancer study
Northwest Herald CHICAGO – Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that's on the rise. Although it's early and the study is small – 35 people – every patient responded and all but two were in … |
